share_log

JP Morgan Maintains Neutral on Agios Pharmaceuticals, Lowers Price Target to $32

Benzinga ·  Aug 7, 2023 11:43

JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and lowers the price target from $33 to $32.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment